M.A.D.W. schreef:
Dit is de reden van de zakking, 1 van de leidinggevende gaat weg bij CRTX ( James B. Tanabaum )
Hij heeft (bijna) al zijn belanghebbende aandelen verkocht. Dus daarom stond het aandeel zo onder druk.
Hieruit kan je concluderen dat wanneer hij klaar het aandeel gelijk omhoog zal gaan. Misschien is hij al klaar of hij zal binnenkort klaar zijn.
Vanda Names New Board Member
Tuesday June 5, 6:08 pm ET
Vanda Names Howard H. Pien to Replace Departing Board Member James B. Tananbaum
ROCKVILLE, Md. (AP) -- Biopharmaceutical company Vanda Pharmaceuticals Inc. said Tuesday it named Howard H. Pien to replace James B. Tananbaum on the company's board.
Pien will also take Tananbaum's place on the board's compensation committee, Vanda said.
A reason was not given for Tananbaum's departure. He has been a board director since 2004, Vanda said.
----------------------------------------------------- -
CRTX Facts
Total Cash (mrq): 45.98M
Total Cash Per Share (mrq): 1.066
Total Debt (mrq): 1.15M
Total Debt/Equity (mrq): 0.025
Current Ratio (mrq): 6.464
Book Value Per Share (mrq): 1.079
This company has enough money for research and development
for other drugs. Many small caps biotech company's has following Book Value Per Share mrg....
AVNR- Book Value Per Share (mrq): -0.145
ENCY-Book Value Per Share (mrq): -1.9
CEGE-Book Value Per Share (mrq): 0.386
IDMI-Book Value Per Share (mrq): 0.894
EXAS-Book Value Per Share (mrq): 0.506
NRMX-Book Value Per Share (mrq): -0.615
CRTX-Book Value Per Share (mrq): 1.079
Earlier this month, Critical Therapeutics said it plans to increase its sales force by at least 40 representatives.
They will make you sone money.
This stock is down because of James B. Tananbaum selling,
he invested in JAZZ alot of money. He is also out from Vanda
There will be PR soon, maybe with in couple a days.
BUY BUY BUY